Ticker LaunchLaw firm
Goodwin Procter
Goodwin Procter is named in the Legal Matters section of 119 US IPO and 20 SPAC IPO prospectuses tracked by Ticker Launch since 2019, as company counsel on 81 and underwriters' counsel on 58.
US IPOs119
SPAC IPOs20
Deals by year: 2026: 11 · 2025: 4 · 2024: 9 · 2023: 2 · 2022: 5 · 2021: 55 · 2020: 38 · 2019: 15
Deals
| Company | Type | Date | Size | Role |
|---|---|---|---|---|
| Frazier Life Sciences Acquisition Corp. II | SPAC IPO | Oct 14, 2026 | $75M | Company counsel |
| Rainier Acquisition Corp | SPAC IPO | Aug 27, 2026 | $75M | Company counsel |
| Braveheart Bio, Inc. | IPO | Aug 6, 2026 | $382.5M | Company counsel |
| TCGX Acquisition Corp. | SPAC IPO | Aug 6, 2026 | $75M | Underwriters' counsel |
| Apnimed, Inc. | IPO | Jul 31, 2026 | $192M | Company counsel |
| Parabilis Medicines, Inc. | IPO | Jun 10, 2026 | $670M | Company counsel |
| Eloxx Pharmaceuticals, Inc. | IPO | Jun 9, 2026 | — | Underwriters' counsel |
| Hemab Therapeutics Holdings, Inc. | IPO | May 1, 2026 | $301.5M | Underwriters' counsel |
| Seaport Therapeutics, Inc. | IPO | May 1, 2026 | $254.9M | Company counsel |
| Avalyn Pharma Inc. | IPO | Apr 30, 2026 | $300M | Company counsel |
| Generate Biomedicines, Inc. | IPO | Feb 27, 2026 | $400M | Company counsel |
| Pattern Group Inc. | IPO | Sep 19, 2025 | $300M | Company counsel |
| Netskope Inc | IPO | Sep 18, 2025 | $908.2M | Underwriters' counsel |
| Sionna Therapeutics, Inc. | IPO | Feb 7, 2025 | $190.6M | Company counsel |
| Metsera, Inc. | IPO | Jan 31, 2025 | $275M | Underwriters' counsel |
| Septerna, Inc. | IPO | Oct 25, 2024 | $288M | Company counsel |
| Bicara Therapeutics Inc. | IPO | Sep 13, 2024 | $315M | Company counsel |
| Lineage, Inc. | IPO | Jul 26, 2024 | $4.44B | Underwriters' counsel |
| Rapport Therapeutics, Inc. | IPO | Jun 7, 2024 | $136M | Company counsel |
| PACS Group, Inc. | IPO | Apr 12, 2024 | $450M | Underwriters' counsel |
| Astera Labs, Inc. | IPO | Mar 21, 2024 | — | Company counsel |
| Metagenomi Therapeutics, Inc. | IPO | Feb 12, 2024 | $93.8M | Company counsel |
| American Healthcare REIT, Inc. | IPO | Feb 8, 2024 | $672M | Underwriters' counsel |
| Fractyl Health, Inc. | IPO | Feb 2, 2024 | $110M | Underwriters' counsel |
| Klaviyo, Inc. | IPO | Sep 20, 2023 | $576M | Company counsel |
| Sagimet Biosciences Inc. | IPO | Jul 17, 2023 | — | Company counsel |
| Acrivon Therapeutics, Inc. | IPO | Nov 16, 2022 | $94.4M | Underwriters' counsel |
| Prime Medicine, Inc. | IPO | Oct 21, 2022 | $175M | Company counsel |
| PepGen Inc. | IPO | May 9, 2022 | $108M | Company counsel |
| Amylyx Pharmaceuticals, Inc. | IPO | Jan 10, 2022 | $190M | Company counsel |
| Vigil Neuroscience, Inc. | IPO | Jan 10, 2022 | $98M | Company counsel |
| Neuphoria Therapeutics Inc. | IPO | Dec 17, 2021 | — | Underwriters' counsel |
| Genenta Science S.p.A. | IPO | Dec 15, 2021 | $35.9M | Underwriters' counsel |
| Chain Bridge I | SPAC IPO | Nov 12, 2021 | $200M | Company counsel |
| CI&T Inc | IPO | Nov 10, 2021 | $195.7M | Underwriters' counsel |
| Real Good Food Company, Inc. | IPO | Nov 8, 2021 | $64M | Underwriters' counsel |
| Aura Biosciences, Inc. | IPO | Nov 1, 2021 | $75.6M | Company counsel |
| Entrada Therapeutics, Inc. | IPO | Nov 1, 2021 | — | Company counsel |
| Enfusion, Inc. | IPO | Oct 22, 2021 | — | Company counsel |
| Exscientia plc | IPO | Oct 4, 2021 | — | Underwriters' counsel |
| Omega Therapeutics, Inc. | IPO | Aug 2, 2021 | $125.8M | Underwriters' counsel |
| Rani Therapeutics Holdings, Inc. | IPO | Aug 2, 2021 | $73.3M | Underwriters' counsel |
| Candel Therapeutics, Inc. | IPO | Jul 28, 2021 | $72M | Company counsel |
| MeridianLink, Inc. | IPO | Jul 28, 2021 | $343.2M | Company counsel |
| Alpha Healthcare Acquisition Corp. III | SPAC IPO | Jul 27, 2021 | $150M | Company counsel |
| Absci Corp | IPO | Jul 23, 2021 | $200M | Company counsel |
| Phillips Edison & Company, Inc. | IPO | Jul 16, 2021 | $476M | Underwriters' counsel |
| Blend Labs, Inc. | IPO | Jul 16, 2021 | $360M | Underwriters' counsel |
| Rapid Micro Biosystems, Inc. | IPO | Jul 16, 2021 | — | Underwriters' counsel |
| Sera Prognostics, Inc. | IPO | Jul 16, 2021 | — | Underwriters' counsel |
| Jade Biosciences, Inc. | IPO | Jun 30, 2021 | — | Company counsel |
| LENZ Therapeutics, Inc. | IPO | Jun 28, 2021 | $238M | Company counsel |
| NeueHealth, Inc. | IPO | Jun 25, 2021 | — | Underwriters' counsel |
| Doximity, Inc. | IPO | Jun 25, 2021 | $605.8M | Company counsel |
| Ambrx Biopharma Cayman, Inc. | IPO | Jun 21, 2021 | $126M | Underwriters' counsel |
| Femasys Inc | IPO | Jun 21, 2021 | — | Underwriters' counsel |
| G Squared Ascend II, Inc. | SPAC IPO | Jun 16, 2021 | $125M | Company counsel |
| 1stdibs.com, Inc. | IPO | Jun 10, 2021 | $115M | Underwriters' counsel |
| Marqeta, Inc. | IPO | Jun 10, 2021 | $1.23B | Company counsel |
| Centessa Pharmaceuticals plc | IPO | Jun 1, 2021 | $330M | Company counsel |
| Flywire Corp | IPO | May 26, 2021 | $250.6M | Underwriters' counsel |
| Vera Therapeutics, Inc. | IPO | May 17, 2021 | $47.9M | Underwriters' counsel |
| Valneva SE | IPO | May 7, 2021 | $93.5M | Underwriters' counsel |
| Privia Health Group, Inc. | IPO | Apr 30, 2021 | $448.5M | Underwriters' counsel |
| Barinthus Biotherapeutics plc. | IPO | Apr 30, 2021 | — | Company counsel |
| FTC Solar, Inc. | IPO | Apr 29, 2021 | — | Underwriters' counsel |
| KnowBe4, Inc. | IPO | Apr 23, 2021 | $152M | Underwriters' counsel |
| ImageneBio, Inc. | IPO | Mar 26, 2021 | $125M | Company counsel |
| Olink Holding AB (publ) | IPO | Mar 26, 2021 | — | Company counsel |
| ThredUp Inc. | IPO | Mar 26, 2021 | $168M | Company counsel |
| SEMrush Holdings, Inc. | IPO | Mar 25, 2021 | — | Company counsel |
| Finch Therapeutics Group, Inc. | IPO | Mar 22, 2021 | $127.5M | Underwriters' counsel |
| Research Alliance Corp. II | SPAC IPO | Mar 19, 2021 | $130M | Company counsel |
| Olo Inc. | IPO | Mar 18, 2021 | $450M | Underwriters' counsel |
| Revolution Healthcare Acquisition Corp. | SPAC IPO | Mar 18, 2021 | $500M | Company counsel |
| Property Solutions Acquisition Corp. II | SPAC IPO | Mar 5, 2021 | $300M | Company counsel |
| Oscar Health, Inc. | IPO | Mar 4, 2021 | $1.44B | Underwriters' counsel |
| Decibel Therapeutics, Inc. | IPO | Feb 12, 2021 | $127.1M | Underwriters' counsel |
| Fifth Wall Acquisition Corp. I | SPAC IPO | Feb 8, 2021 | $300M | Company counsel |
| Faeth Therapeutics, Inc. | IPO | Feb 4, 2021 | $133M | Underwriters' counsel |
| BlueRiver Acquisition Corp. | SPAC IPO | Feb 1, 2021 | $250M | Company counsel |
| Qualtrics International Inc. | IPO | Jan 29, 2021 | $1.55B | Underwriters' counsel |
| Poshmark, Inc. | IPO | Jan 14, 2021 | $277.2M | Company counsel |
| Cullinan Therapeutics, Inc. | IPO | Jan 11, 2021 | $249.9M | Company counsel |
| Powered Brands | SPAC IPO | Jan 11, 2021 | $240M | Company counsel |
| Omega Alpha SPAC | SPAC IPO | Jan 8, 2021 | $120M | Company counsel |
| 908 Devices Inc. | IPO | Dec 18, 2020 | — | Company counsel |
| AbCellera Biologics Inc. | IPO | Dec 14, 2020 | $483M | Company counsel |
| Thayer Ventures Acquisition Corporation | SPAC IPO | Dec 11, 2020 | $150M | Company counsel |
| Frazier Lifesciences Acquisition Corp | SPAC IPO | Dec 10, 2020 | $120M | Company counsel |
| DoorDash, Inc. | IPO | Dec 9, 2020 | $3.37B | Underwriters' counsel |
| Damora Therapeutics, Inc. | IPO | Oct 30, 2020 | $85M | Company counsel |
| SQZ Biotechnologies Co | IPO | Oct 30, 2020 | $70.6M | Underwriters' counsel |
| Root, Inc. | IPO | Oct 29, 2020 | $724.4M | Underwriters' counsel |
| Opthea Ltd | IPO | Oct 19, 2020 | — | Underwriters' counsel |
| Praxis Precision Medicines, Inc. | IPO | Oct 16, 2020 | $190M | Company counsel |
| Codiak BioSciences, Inc. | IPO | Oct 14, 2020 | $82.5M | Company counsel |
| Immunome Inc. | IPO | Oct 5, 2020 | — | Underwriters' counsel |
| C4 Therapeutics, Inc. | IPO | Oct 2, 2020 | $182.4M | Company counsel |
| Vy Global Growth | SPAC IPO | Oct 2, 2020 | $500M | Company counsel |
| Taysha Gene Therapies, Inc. | IPO | Sep 25, 2020 | $157.4M | Underwriters' counsel |
| Bentley Systems Inc | IPO | Sep 24, 2020 | — | Underwriters' counsel |
| Laird Superfood, Inc. | IPO | Sep 23, 2020 | $58.3M | Underwriters' counsel |
| COMPASS Pathways plc | IPO | Sep 21, 2020 | $127.5M | Company counsel |
| Snowflake Inc. | IPO | Sep 16, 2020 | $3.36B | Underwriters' counsel |
| Ribbit LEAP, Ltd. | SPAC IPO | Sep 14, 2020 | $350M | Company counsel |
| Kymera Therapeutics, Inc. | IPO | Aug 21, 2020 | $173.7M | Company counsel |
| Harmony Biosciences Holdings, Inc. | IPO | Aug 20, 2020 | $128.4M | Underwriters' counsel |
| one (AONE) | SPAC IPO | Aug 19, 2020 | $200M | Company counsel |
| IBEX Ltd | IPO | Aug 10, 2020 | $90.5M | Underwriters' counsel |
| Freeline Therapeutics Holdings plc | IPO | Aug 10, 2020 | $158.8M | Underwriters' counsel |
| Checkmate Pharmaceuticals, Inc. | IPO | Aug 7, 2020 | $75M | Company counsel |
| Kalaris Therapeutics, Inc. | IPO | Jul 30, 2020 | $276.2M | Company counsel |
| Renalytix plc | IPO | Jul 17, 2020 | — | Underwriters' counsel |
| Pandion Therapeutics, Inc. | IPO | Jul 17, 2020 | $135M | Underwriters' counsel |
| Relay Therapeutics, Inc. | IPO | Jul 16, 2020 | $400M | Company counsel |
| PTK Acquisition Corp. | SPAC IPO | Jul 15, 2020 | $100M | Company counsel |
| Therapeutics Acquisition Corp. (d/b/a Research Alliance Corp. I) | SPAC IPO | Jul 9, 2020 | $118M | Company counsel |
| Fusion Pharmaceuticals Inc. | IPO | Jun 26, 2020 | $212.5M | Company counsel |
| Forma Therapeutics Holdings, Inc. | IPO | Jun 22, 2020 | $277.6M | Company counsel |
| Repare Therapeutics Inc. | IPO | Jun 19, 2020 | $220M | Underwriters' counsel |
| Royalty Pharma plc | IPO | Jun 17, 2020 | $2.18B | Underwriters' counsel |
| Calliditas Therapeutics AB | IPO | Jun 8, 2020 | — | Company counsel |
| Pliant Therapeutics, Inc. | IPO | Jun 3, 2020 | $144M | Company counsel |
| Centogene N.V. | IPO | Nov 8, 2019 | $56M | Underwriters' counsel |
| Cabaletta Bio, Inc. | IPO | Oct 25, 2019 | $74.8M | Company counsel |
| Dynatrace, Inc. | IPO | Aug 1, 2019 | $569.8M | Company counsel |
| Health Catalyst, Inc. | IPO | Jul 25, 2019 | $182M | Company counsel |
| BridgeBio Pharma, Inc. | IPO | Jun 28, 2019 | $348.5M | Company counsel |
| Karuna Therapeutics, Inc. | IPO | Jun 28, 2019 | $89.2M | Company counsel |
| Bicycle Therapeutics PLC | IPO | May 23, 2019 | $60.7M | Company counsel |
| DNA X, Inc. | IPO | May 13, 2019 | $39.3M | Underwriters' counsel |
| Axcella Health Inc. | IPO | May 9, 2019 | $71.4M | Company counsel |
| HOOKIPA Pharma Inc. | IPO | Apr 19, 2019 | $84M | Company counsel |
| Tufin Software Technologies Ltd. | IPO | Apr 11, 2019 | — | Underwriters' counsel |
| Lyft, Inc. | IPO | Mar 29, 2019 | — | Underwriters' counsel |
| Genfit S.A. | IPO | Mar 27, 2019 | $135.1M | Underwriters' counsel |
| Kaleido Biosciences, Inc. | IPO | Mar 1, 2019 | $75M | Company counsel |
| TCR2 Therapeutics Inc. | IPO | Feb 15, 2019 | $75M | Company counsel |
See where Goodwin Procter ranks: US IPOs · SPAC IPOs
Track Goodwin Procter's next deals
Subscribers get each new filing and pricing the morning after, with alerts and Excel export.